Table of Contents
<< Previous Issue | Feb 2005 (Vol: 2005, Issue: 56) | Next Issue >> |
- Section: Business Commentaries
-
Preparing to Walk Away
- Section: Deal Trackers
-
Tysabri (natalizumab)
- Section: Distribution & Marketing
-
GSK Transfers Levitra® Co-Promotion Rights Back to Bayer
- Section: Features
-
Ortho-McNeil's Re-Entry into the Diabetes Arena
-
CAT and Abbott: A David and Goliath Story
-
Deal Making in the Biopharmaceutical Sector
-
Therapy Focus: Malaria
- Section: General
-
Corixa Hands Over Bexxar® Rights to GSK
-
Micromet AG
- Section: Licensing
-
Centocor Partners Neurochem to Gain Access to Amyloidosis Drug
- Section: Mergers & Acquisitions
-
Johnson & Johnson’s US$25.4 B Acquisition of Guidant
-
Solvay Pharmaceuticals Launches Friendly Takeover Bid for Neopharma
- Section: Research & Development
-
Infinity’s Small Molecule Collaborations with Big Pharma